BIO-RAD LAB-A
BIO-RAD LAB-A operates in Diversified Metals & Mining.
BIO-RAD LAB-A (BUWA) - Net Assets
Latest net assets as of September 2024: €7.49 Billion EUR
Based on the latest financial reports, BIO-RAD LAB-A (BUWA) has net assets worth €7.49 Billion EUR as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€10.60 Billion) and total liabilities (€3.12 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €7.49 Billion |
| % of Total Assets | 70.62% |
| Annual Growth Rate | 19.01% |
| 5-Year Change | 51.89% |
| 10-Year Change | N/A |
| Growth Volatility | 31.9 |
BIO-RAD LAB-A - Net Assets Trend (2016–2023)
This chart illustrates how BIO-RAD LAB-A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BIO-RAD LAB-A (2016–2023)
The table below shows the annual net assets of BIO-RAD LAB-A from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | €8.74 Billion | -9.09% |
| 2022-12-31 | €9.62 Billion | -29.74% |
| 2021-12-31 | €13.69 Billion | +38.52% |
| 2020-12-31 | €9.88 Billion | +71.67% |
| 2019-12-31 | €5.76 Billion | +43.15% |
| 2018-12-31 | €4.02 Billion | +37.20% |
| 2017-12-31 | €2.93 Billion | +13.28% |
| 2016-12-31 | €2.59 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to BIO-RAD LAB-A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 404.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €9.26 Billion | 105.94% |
| Total Equity | €8.74 Billion | 100.00% |
BIO-RAD LAB-A Competitors by Market Cap
The table below lists competitors of BIO-RAD LAB-A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mercator Limited
NSE:MERCATOR
|
$2.58 Million |
|
Art Nirman Limited
NSE:ARTNIRMAN
|
$2.58 Million |
|
AppSpotr AB
ST:APTR
|
$2.58 Million |
|
Public Company Management Corp
PINK:PCMC
|
$2.58 Million |
|
MIRAI CORP.
F:837
|
$2.58 Million |
|
Bait Bakfar Ltd
TA:BKFR
|
$2.58 Million |
|
ALNYLAM PHARMA
MU:DUL
|
$2.58 Million |
|
PT Sari Kreasi Boga Tbk
JK:RAFI
|
$2.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BIO-RAD LAB-A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 9,615,252,000 to 8,741,133,000, a change of -874,119,000 (-9.1%).
- Net loss of 637,324,000 reduced equity.
- Share repurchases of 428,728,000 reduced equity.
- Other factors increased equity by 191,933,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-637.32 Million | -7.29% |
| Share Repurchases | €428.73 Million | -4.9% |
| Other Changes | €191.93 Million | +2.2% |
| Total Change | €- | -9.09% |
Book Value vs Market Value Analysis
This analysis compares BIO-RAD LAB-A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.83x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.60x to 0.83x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | €98.38 | €255.80 | x |
| 2018-12-31 | €134.91 | €255.80 | x |
| 2019-12-31 | €192.31 | €255.80 | x |
| 2020-12-31 | €331.05 | €255.80 | x |
| 2021-12-31 | €457.20 | €255.80 | x |
| 2022-12-31 | €324.89 | €255.80 | x |
| 2023-12-31 | €306.51 | €255.80 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BIO-RAD LAB-A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.29%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -23.86%
- • Asset Turnover: 0.22x
- • Equity Multiplier: 1.41x
- Recent ROE (-7.29%) is below the historical average (8.70%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 1.09% | 1.36% | 0.54x | 1.49x | €-230.55 Million |
| 2017 | 4.17% | 5.66% | 0.51x | 1.46x | €-170.78 Million |
| 2018 | 9.09% | 15.97% | 0.41x | 1.40x | €-36.42 Million |
| 2019 | 30.56% | 76.08% | 0.29x | 1.39x | €1.18 Billion |
| 2020 | 38.61% | 149.83% | 0.20x | 1.31x | €2.83 Billion |
| 2021 | 31.09% | 145.57% | 0.16x | 1.30x | €2.89 Billion |
| 2022 | -37.73% | -129.45% | 0.21x | 1.40x | €-4.59 Billion |
| 2023 | -7.29% | -23.86% | 0.22x | 1.41x | €-1.51 Billion |
Industry Comparison
This section compares BIO-RAD LAB-A's net assets metrics with peer companies in the Other industry.
Industry Context
- Industry: Other
- Average net assets among peers: $107,279,526,363
- Average return on equity (ROE) among peers: 7.07%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BIO-RAD LAB-A (BUWA) | €7.49 Billion | 1.09% | 0.42x | $2.58 Million |
| HORIBA (01H) | $204.49 Billion | 10.42% | 0.82x | $973.51K |
| Tokyu Corporation (01T) | $747.05 Billion | 9.38% | 2.03x | $93.98K |
| GUANGZHOU AUTO -H- (02G) | $77.92 Billion | 13.99% | 0.70x | $4.23K |
| MOSAIC (02M) | $9.37 Billion | -11.39% | 1.06x | $267.55K |
| MOSAIC (02M.SG) (02M) | $10.72 Billion | 9.59% | 0.71x | $264.31K |
| CHINA JO-JO DRGSTRS (04CN.SG) (04CN) | $22.74 Million | -14.04% | 3.68x | $1.51 Million |
| KRAKATAU STEEL -B- (07K) | $587.19 Million | 7.57% | 5.43x | $166.88 |
| CN MODERN DAIRY (07M.SG) (07M) | $8.04 Billion | 9.58% | 0.94x | $1.66K |
| TOURMALINE OIL (08T) | $13.69 Billion | 32.78% | 0.38x | $376.57K |
| ASIA CASSAVA RESOUR (0ACS) | $913.15 Million | 2.86% | 1.55x | $343.89 |